Quetzal Site 12 — Nashville, Tennessee

Quetzal Site 12 is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Quetzal Site 12 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia, Acute Promyelocytic Leukemia With PML-RARA.

Sponsors: Quetzal Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Quetzal Site 12?

Quetzal Site 12 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Quetzal Site 12 conducted?

Quetzal Site 12 has 1 clinical trials on record, with 1 currently active. Their work covers Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia, Acute Promyelocytic Leukemia With PML-RARA.

Is Quetzal Site 12 accredited by Crixeo Clinical Trials?

Quetzal Site 12 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Quetzal Site 12?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.